STRATA Skin Sciences Announces New Recurring Revenue Direct Distribution Contract with JMEC Co., Ltd. in Japan
HORSHAM, Pa., Sept. 14, 2020 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in […]
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Recruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN […]
Avadel Pharmaceuticals Announces FT218 Leadership Transition
Jordan Dubow, M.D. stepping down as CMO and will continue as a consultant to the Company through the FT218 NDA […]
Oxford Square Capital Corp. Declares Common Stock Distributions for the Months Ending October 31, November 30, and December 31, 2020
GREENWICH, Conn., Sept. 14, 2020 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (the “Company,” […]
VYNE Therapeutics Announces the Appointment of Patrick G. LePore to its Board of Directors
BRIDGEWATER, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that […]
OneWater Marine Inc. Announces Public Offering of Common Stock
BUFORD, Ga., Sept. 14, 2020 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) announced today that […]
LexinFintech Announces Business Updates, Senior Management Announces Management Share Purchase Plan
SHENZHEN, China, Sept. 14, 2020 (GLOBE NEWSWIRE) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading online […]
Biogen to Invest $250 Million in a 20-year Initiative to Eliminate its Use of Fossil Fuels and Improve Public Health
After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil […]
InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia
First site initiated for enrollment in the NetherlandsRegulatory approval granted to start trial in GermanyAdditional sites to be added in […]
Cassava Sciences Announces Final Results of a Phase 2b Clinical Study of Sumifilam in Patients with Alzheimer’s Disease
Alzheimer’s Patients in Drug Groups Showed Statistically Significant Improvements in Biomarkers of Disease Compared to Placebo Group (P<0.05)Alzheimer’s Patients in […]
